- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-VEGF Treatment Strategies for Wet AMD
Authors
Keywords
-
Journal
Journal of Ophthalmology
Volume 2012, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2012-02-29
DOI
10.1155/2012/786870
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bevacizumab versus Ranibizumab for AMD
- (2011) Philip J. Rosenfeld NEW ENGLAND JOURNAL OF MEDICINE
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2
- (2010) Prema Abraham et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Retrospective study of an as required dosing regimen of intravitreal bevacizumab in neovascular age-related macular degeneration in an Australian population
- (2010) Susie T Luu et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at Twenty-four Months: The Pan-American Collaborative Retina Study
- (2010) J. Fernando Arevalo et al. OPHTHALMOLOGY
- A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationClinical and Economic Impact
- (2010) Omesh P. Gupta et al. OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- INJECT AND EXTEND DOSING VERSUS DOSING AS NEEDED
- (2010) Hassiba Oubraham et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Effect of intravitreal bevacizumab (Avastin®) in neovascular age-related macular degeneration using a treatment regimen based on optical coherence tomography: 6- and 12-month results
- (2009) Christina Leydolt et al. ACTA OPHTHALMOLOGICA
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective Study
- (2009) Ziad F. Bashshur et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
- (2009) David S. Boyer et al. OPHTHALMOLOGY
- Introduction: Understanding the Role of Angiogenesis and Antiangiogenic Agents in Age-Related Macular Degeneration
- (2009) Susan B. Bressler OPHTHALMOLOGY
- “TREAT AND EXTEND” DOSING OF INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR TYPE 3 NEOVASCULARIZATION/RETINAL ANGIOMATOUS PROLIFERATION
- (2009) MICHAEL ENGELBERT et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab
- (2008) A Y Lee et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment
- (2008) Kenneth CS Fong et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now